14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
MPW vs SBRA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Sabra Healthcare REIT, Inc. (SBRA) captures the overall head-to-head institutional edge over Medical Properties Trust, Inc. (MPW) on higher Unified Composite conviction (56.4/100 HOLD vs. 52.6/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Options & Positioning), while MPW wins 4–2 across the 6-pillar growth and valuation breakdown. MPW trades at $5.02 (6.7x Forward P/E, 58.2% operating margin) versus SBRA at $20.42 (28.2x Forward P/E, 18.4% operating margin).
Growth vs. Quality Trade-Off: SBRA earns the overall head-to-head edge with a stronger Unified Composite Score (56.4/100 HOLD vs. MPW 52.6/100 HOLD) and -0.01β · 31% Vol risk profile, whereas MPW leads top-line expansion (+9.9% YoY revenue growth, 1.93x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MPW vs SBRA. Trailing 12-month operating profitability (MPW 58.2% vs SBRA 18.4%) and valuation multiples (MPW 6.7x vs SBRA 28.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the REIT - Healthcare Facilities value chain with $5.4B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment31.2% of Rev ($288M)
90D Engineering Disclosures0 Published
Investor FAQ MPW vs SBRA Key Questions & Quantitative Answers
As of Nov 16, 2026, Sabra Healthcare REIT, Inc. (SBRA) captures the overall head-to-head institutional edge over Medical Properties Trust, Inc. (MPW) on higher Unified Composite conviction (56.4/100 HOLD vs. 52.6/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Options & Positioning), while MPW wins 4–2 across the 6-pillar growth and valuation breakdown. MPW trades at $5.02 (6.7x Forward P/E, 58.2% operating margin) versus SBRA at $20.42 (28.2x Forward P/E, 18.4% operating margin). Growth vs. Quality Trade-Off: SBRA earns the overall head-to-head edge with a stronger Unified Composite Score (56.4/100 HOLD vs. MPW 52.6/100 HOLD) and -0.01β · 31% Vol risk profile, whereas MPW leads top-line expansion (+9.9% YoY revenue growth, 1.93x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
SBRA leads the Growth & Scale pillar: MPW posts +9.9% YoY revenue growth and -48.6% YoY earnings growth on $1.01B TTM revenue (96.4% gross margin, 58.2% operating margin), compared with SBRA at +31.6% YoY revenue growth and +22.2% YoY earnings growth on $924M TTM revenue (49.6% gross margin, 18.4% operating margin). On trailing 12-month operating scale, MPW generates $1.01B in USD-normalized revenue versus $924M for SBRA. In operating R&D and SG&A reinvestment, MPW deploys 38.2% of Rev ($385M) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($288M) (0 disclosures) for SBRA.
MPW screens cheaper on headline valuation multiples. MPW trades at 6.7x Forward P/E, 6.7x Trailing P/E, 1.93x PEG, and 3.0x EV/Revenue (81.6% EBITDA margin), whereas SBRA trades at 28.2x Forward P/E, 76.2x Trailing P/E, 5.28x PEG, and 8.4x EV/Revenue (43.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MPW (-14.0% ROE) versus SBRA (2.5% ROE) capital efficiency.
In options market volatility and institutional positioning, MPW carries 24.3% implied volatility (25th %ile, Balanced (25th–60th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.14β · 26% Vol realized risk). By comparison, SBRA carries 21.6% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.01β · 31% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.